About: Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 2007

AttributesValues
rdf:type
description
  • wetenschappelijk artikel (nl)
  • article scientifique (publié 2007) (fr)
  • наукова стаття, опублікована в січні 2007 (uk)
  • im Januar 2007 veröffentlichter wissenschaftlicher Artikel (de)
  • artículu científicu espublizáu en xineru de 2007 (ast)
  • artikull shkencor i botuar më 01 janar 2007 (sq)
  • scientific article published on 01 January 2007 (en)
publication date
publication date
author name string
author name string
  • R Phillips
  • W Heller
  • R Ward
  • R C Coombes
  • C Palmieri
  • S Shousha
  • D Mazhar
  • H D Sinnett
  • A Fayaz
  • C Lowdell
rdfs:label
  • Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer (en)
  • Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer (nl)
  • Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer (sq)
skos:prefLabel
  • Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer (en)
  • Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer (nl)
  • Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer (sq)
name
  • Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer (en)
  • Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer (nl)
  • Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer (sq)
title
title
  • Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer (en)
page(s)
page(s)
  • 253-259
instance of
instance of
main subject
main subject
PubMed ID
PubMed ID
PubMed ID
  • 17143506
published in
published in
issue
volume
issue
  • 1
volume
  • 17
DOI
DOI
DOI
  • 10.3892/OR.17.1.253
is about of
is cites work of
is cites work of
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software